🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The ProVent study is a randomized, open-label study designed to assess the ...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2018-10-18
Trial ID
NCT03686683
Treatments Being Tested
The stud will evaluate whether infusions of CD45RA-depleted lymphocytes fro...
Status
Completed
Location
Federal Research Center for pediatric hematology, oncology and immunology
Start Date
2014-08
Trial ID
NCT02337595
Treatments Being Tested
Evaluate the safety, pharmacokinetic (PK) characteristics, and pharmacodyna...
Status
Recruiting
Location
PersonGen.Anke Cellular Therapeutice Co., Ltd.
Start Date
2025-09-25
Trial ID
NCT07312630
Treatments Being Tested
This protocol will enroll subjects with advanced hematologic malignancies w...
Status
Completed
Location
University of Pennsylvania
Start Date
2009-01
Trial ID
NCT00891592
Treatments Being Tested
This is a a phase 1, open label study to assess the safety and efficacy of ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10-15
Trial ID
NCT05576181
Treatments Being Tested
The purpose of this research study is to learn more about the use of viral ...
Status
Withdrawn
Location
Cincinnati Children's Hospital Medical Center
Start Date
2021-01
Trial ID
NCT04406064
Treatments Being Tested
Alloimmune-mediated platelet transfusion refractoriness(PTR) was usually ca...
Status
Unknown
Location
The First Affiliated Hospital of Soochow University
Start Date
2021-04-29
Trial ID
NCT04846439
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, PK and ...
Status
Recruiting
Location
City of Hope
Start Date
2026-09
Trial ID
NCT07192471
Treatments Being Tested
The purpose of this clinical trial is to learn if allogeneic cord blood-der...
Status
Recruiting
Location
Xi'an No.3 Hospital
Start Date
2024-10-03
Trial ID
NCT07139509
Treatments Being Tested
Acute myeloid leukemia (AML) is a common type of acute leukemia in adults. ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02
Trial ID
NCT07432100
Treatments Being Tested